Physical Medicine & Rehabilitation, Pain Medicine · White Plains, NY
NPI
1457465585
Since 2006
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
14 Mamaroneck Ave Fl 2
White Plains, NY, 10601
Phone (914) 949-5555
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
2,373 services
Medicare patients, 2024
72
Average age 70
Drug cost, 2024
$705K
4,317 prescriptions
Company payments, 2024
$445
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria M Cabodevilla-Conn was code 99214 (office e&m - established), 177 times for 50 patients. In total Maria M Cabodevilla-Conn billed 2,373 services in 27 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 177 | 50 | $105.94 | $19K |
| 80305 Drug Tests | Office | 63 | 19 | $12.35 | $778 |
| 99213 Office E&M - Established | Office | 45 | 31 | $79.42 | $3,574 |
| 82962 Clinical Chemistry | Office | 41 | 19 | $3.21 | $132 |
| 99204 Office E&M - New | Office | 27 | 27 | $131.59 | $3,553 |
By year: 2022 $12K for 184 services; 2023 $31K for 388 services; 2024 $32K for 2,373 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 63 | 19 | $12.35 | $778 |
| 82962 Clinical Chemistry | 41 | 19 | $3.21 | $132 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria M Cabodevilla-Conn prescribed most often to Medicare patients was Gabapentin, with 544 prescriptions and refills. In total Maria M Cabodevilla-Conn wrote 4,317 Medicare prescriptions that cost $705K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 544 | 580 | 173 | $4,702 |
| Cyclobenzaprine Hcl Generic | 529 | 546 | 204 | $4,481 |
| Methocarbamol Generic | 374 | 388 | 125 | $4,404 |
| Oxycodone Hcl Generic | 347 | 347 | 56 | $4,523 |
| Meloxicam Generic | 295 | 311 | 106 | $1,041 |
| Diclofenac Sodium Generic | 267 | 280 | 105 | $9,633 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 241 | 241 | 41 | $5,888 |
| Baclofen Generic | 196 | 196 | 64 | $1,682 |
| Qutenza Capsaicin/Skin Cleanser | 170 | 507 | 130 | $597K |
| Naloxone Hcl Generic | 165 | 165 | 55 | $9,735 |
| Tizanidine Hcl Generic | 157 | 173 | 49 | $2,313 |
| Pregabalin Generic | 145 | 145 | 47 | $2,028 |
| Tramadol Hcl Generic | 140 | 140 | 34 | $1,145 |
| Celecoxib Generic | 132 | 143 | 42 | $1,434 |
| Lidocaine Generic | 114 | 132 | 41 | $8,416 |
Brand drugs: 298 claims; generic drugs: 4,019 claims; opioid claims: 828.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Maria M Cabodevilla-Conn $445 ($445 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pacira Pharmaceuticals Incorporated with $327.
| Company | Payments | Amount |
|---|---|---|
| Pacira Pharmaceuticals Incorporated PCRX | 3 | $327 |
| Averitas Pharma Inc. | 4 | $76.73 |
| Ferring Pharmaceuticals Inc. | 2 | $40.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.